跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 70 条关于
“iSPERSE”
全部
70
临床试验
41
药物
22
机构
0
资讯
7
去年
Pulmatrix to Divest Phase 2-Ready Migraine Treatment and iSPERSE Technology Ahead of Cullgen Merger
9个月前
Pulmatrix and Cullgen Mutually Waive No-Solicitation Clause While Awaiting Chinese Regulatory Approval for Merger
去年
Gene Therapy and GPR6 Inverse Agonist Show Promise in Parkinson's Disease Trials
3个月前
The Cancer–Alzheimer's Paradox: Unraveling the Inverse Relationship Between Two Age-Related Diseases
去年
Corbus Pharmaceuticals Initiates Phase 1 Trial of Peripherally Restricted CB1 Inverse Agonist for Obesity
2年前
TAK-906: Peripheral D2/D3 Antagonist Under Development for Gastroparesis
前天
Corbus' Oral CB1 Inverse Agonist CRB-913 Delivers 5% Weight Loss at 12 Weeks in Phase 1b CANYON-1 Trial